Mission Cancer + Blood (Exigent Network) — Des Moines, Iowa

Mission Cancer + Blood (Exigent Network) is a clinical research site located in Des Moines, Iowa, United States 50309.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Mission Cancer + Blood (Exigent Network) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Gastroesophageal-junction Cancer, Monoclonal Antibody, Gastric Cancer.

Sponsors: Shanghai Henlius Biotech.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mission Cancer + Blood (Exigent Network)?

Mission Cancer + Blood (Exigent Network) has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mission Cancer + Blood (Exigent Network) conducted?

Mission Cancer + Blood (Exigent Network) has 1 clinical trials on record, with 1 currently active. Their work covers Gastroesophageal-junction Cancer, Monoclonal Antibody, Gastric Cancer.

Is Mission Cancer + Blood (Exigent Network) accredited by Crixeo Health?

Mission Cancer + Blood (Exigent Network) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mission Cancer + Blood (Exigent Network)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.